Fatima Khan

2.8k total citations · 4 hit papers
38 papers, 1.6k citations indexed

About

Fatima Khan is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Fatima Khan has authored 38 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 16 papers in Immunology and 8 papers in Oncology. Recurrent topics in Fatima Khan's work include Immune cells in cancer (12 papers), Glioma Diagnosis and Treatment (4 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Fatima Khan is often cited by papers focused on Immune cells in cancer (12 papers), Glioma Diagnosis and Treatment (4 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Fatima Khan collaborates with scholars based in United States, South Korea and United Kingdom. Fatima Khan's co-authors include Peiwen Chen, Lizhi Pang, Amy B. Heimberger, Madeline Dunterman, Maciej S. Lesniak, Prakash Gangadaran, Byeong‐Cheol Ahn, Crismita Dmello, Manasi P. Jogalekar and Wenjing Xuan and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Fatima Khan

36 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy

2023 211 citations Fatima Khan, Lizhi Pang et al. Journal of Clinical Investigation profile →
Tumor microenvironment signaling and therapeutics in cancer progression

2023 154 citations Anshika Goenka, Fatima Khan et al. Cancer Communications profile →
CAR T-Cell-Based gene therapy for cancers: new perspectives, challenges, and clinical developments

2022 122 citations Manasi P. Jogalekar, Ramya Lakshmi Rajendran et al. profile →
Lactate dehydrogenase A regulates tumor-macrophage symbiosis to promote glioblastoma progression

2024 70 citations Fatima Khan, Yiyun Lin et al. Nature Communications profile →

Peers

Fatima Khan

ONCOL

IMMUN

GENET

Andrew Deonarine United States

Persio Dello Sbarba Italy

Tobias Weiß Switzerland

Meizhang Li United States

Weidong Xiong United States

Meijing Wu United States

Giuseppe Lamorte Italy

Matthias Schulz Germany

Natalie Rittenhouse United States

Elisabetta Rovida Italy

Andrew Deonarine United States

Fatima Khan

670 ×0.9

1.5k ×2.6

ONCOL

884 ×1.8

IMMUN

324 ×1.2

72 ×0.3

GENET

Citations per year, relative to Fatima Khan Fatima Khan (= 1×) peers Andrew Deonarine

Countries citing papers authored by Fatima Khan

Since Specialization

Citations

This map shows the geographic impact of Fatima Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fatima Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fatima Khan more than expected).

Fields of papers citing papers by Fatima Khan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fatima Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fatima Khan. The network helps show where Fatima Khan may publish in the future.

Co-authorship network of co-authors of Fatima Khan

This figure shows the co-authorship network connecting the top 25 collaborators of Fatima Khan. A scholar is included among the top collaborators of Fatima Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fatima Khan. Fatima Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gangadaran, Prakash, Ramya Lakshmi Rajendran, Anshika Goenka, et al.. (2025). Noninvasive in vivo imaging of macrophages: understanding tumor microenvironments and delivery of therapeutics. Biomarker Research. 13(1). 20–20. 7 indexed citations

Schworer, Stephen A., Rodney C. Gilmore, Fatima Khan, et al.. (2025). TGF-β Receptor–dependent Tissue Factor Release and Proteomic Profiling of Extracellular Vesicles from Mechanically Compressed Human Bronchial Epithelial Cells. American Journal of Respiratory Cell and Molecular Biology. 73(1). 88–95. 1 indexed citations

Liu, Yang, Lizhi Pang, Fatima Khan, et al.. (2025). Glycoprotein NMB mediates bidirectional GSC-TAM interactions to promote tumor progression. JCI Insight. 10(13). 1 indexed citations

Zhu, Hongcheng, et al.. (2024). P4.17D.02 Global Trends in Lung Cancer Survival by Morphology: Analysis from 61 Countries During 2000-2014 (CONCORD-3). Journal of Thoracic Oncology. 19(10). S420–S420.

Gangadaran, Prakash, et al.. (2024). Unveiling Invisible Extracellular Vesicles: Cutting‐Edge Technologies for Their in Vivo Visualization. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology. 16(5). e2009–e2009. 8 indexed citations

Khan, Fatima, Yiyun Lin, Heba Ali, et al.. (2024). Lactate dehydrogenase A regulates tumor-macrophage symbiosis to promote glioblastoma progression. Nature Communications. 15(1). 1987–1987. 70 indexed citations breakdown →

Khan, Fatima, et al.. (2023). Frequency of p53 Mutations and Epstein-Barr Virus in Pakistani Gastric Cancer Patients and Their Association with the Tumor Grade. 3(1). 35–46. 1 indexed citations

Khan, Fatima, et al.. (2023). Oophorectomy in Premenopausal Patients with Estrogen Receptor-Positive Breast Cancer: New Insights into Long-Term Effects. Current Oncology. 30(2). 1794–1804. 4 indexed citations

Goenka, Anshika, Fatima Khan, Priyanka Sinha, et al.. (2023). Tumor microenvironment signaling and therapeutics in cancer progression. Cancer Communications. 43(5). 525–561. 154 indexed citations breakdown →

10.

Khan, Fatima, Lizhi Pang, Madeline Dunterman, et al.. (2023). Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy. Journal of Clinical Investigation. 133(1). 211 indexed citations breakdown →

11.

Pang, Lizhi, Madeline Dunterman, Songlin Guo, et al.. (2023). Kunitz-type protease inhibitor TFPI2 remodels stemness and immunosuppressive tumor microenvironment in glioblastoma. Nature Immunology. 24(10). 1654–1670. 39 indexed citations

12.

Pang, Lizhi, Madeline Dunterman, Wenjing Xuan, et al.. (2023). Circadian regulator CLOCK promotes tumor angiogenesis in glioblastoma. Cell Reports. 42(2). 112127–112127. 50 indexed citations

13.

Pang, Lizhi, Songlin Guo, Fatima Khan, et al.. (2023). Hypoxia-driven protease legumain promotes immunosuppression in glioblastoma. Cell Reports Medicine. 4(11). 101238–101238. 32 indexed citations

14.

Xuan, Wenjing, Wen-Hao Hsu, Fatima Khan, et al.. (2022). Circadian Regulator CLOCK Drives Immunosuppression in Glioblastoma. Cancer Immunology Research. 10(6). 770–784. 80 indexed citations

15.

Pang, Lizhi, Fatima Khan, Amy B. Heimberger, & Peiwen Chen. (2022). Mechanism and therapeutic potential of tumor-immune symbiosis in glioblastoma. Trends in cancer. 8(10). 839–854. 44 indexed citations

16.

Khan, Fatima, Xiaobing Yu, & Edward C. Hsiao. (2021). Cardiopulmonary and Neurologic Dysfunctions in Fibrodysplasia Ossificans Progressiva. Biomedicines. 9(2). 155–155. 7 indexed citations

17.

Xuan, Wenjing, Fatima Khan, C. David James, et al.. (2021). Circadian regulation of cancer cell and tumor microenvironment crosstalk. Trends in Cell Biology. 31(11). 940–950. 77 indexed citations

18.

Khan, Fatima, Gowri Rangaswamy Gunassekaran, Sri Murugan Poongkavithai Vadevoo, et al.. (2020). Phage display-identified PD-L1-binding peptides reinvigorate T-cell activity and inhibit tumor progression. Biomaterials. 247. 119984–119984. 62 indexed citations

19.

Khan, Fatima, Sri Murugan Poongkavithai Vadevoo, Rang‐Woon Park, et al.. (2018). A Phage Display-Identified Peptide Selectively Binds to Kidney Injury Molecule-1 (KIM-1) and Detects KIM-1-Overexpressing Tumors in vivo. Cancer Research and Treatment. 51(3). 861–875. 13 indexed citations

20.

Khan, Fatima, et al.. (2000). Predictors of tobacco and alcohol consumption and their relevance to oral cancer control amongst people from minority ethnic communities in the south thames health region.. Journal of Dental Research. 79(5). 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact